Trials / Recruiting
RecruitingNCT06138236
Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides
Comparison of ESWT and Collagen Hydrolyzed Peptides in the Treatment of Plantar Fascitiis
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.
Detailed description
Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments. Aim of the study was to consider any difference in the outcome of the three groups of patients. The NRS and the AFAS score were considered for the outcome measurement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Collagen hydrolyzed peptides | infiltration near the heal spur of 2ml of Arthrys |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-11-18
- Last updated
- 2025-12-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06138236. Inclusion in this directory is not an endorsement.